Where GenAI fits in Life Sciences

Generative AI isn’t just a topic for conferences anymore – it’s becoming part of everyday work in life sciences. But with all the noise out there, it’s easy to lose track of where it actually supports. At Capptoo Group – and through our work at Screver – we’ve been closely observing where GenAI is already proving useful, especially across medical, commercial, and operational teams.

Here’s what’s working – and why.

1. Supporting Field Teams with What They Need, When They Need It

Forget quarterly segmentation slides and static reports. GenAI is helping field teams:

• Use up-to-date CRM, claims, and digital activity to guide decisions
  
  
• Understand HCP preferences and suggest timely next steps
  
  
• Pull together summaries on local trends, questions, or competitor activity
  

It’s not replacing reps. It’s giving them better tools to make their next move count.

2. Smoother Patient Journeys, Fewer Gaps

Behind the scenes, GenAI is helping support teams run more smoothly. From enrolment to follow-ups, it assists by:

• Automating common queries
  
• Flagging where patients get stuck
  
• Creating faster, more consistent experiences
  

This reduces friction – and helps more patients stay on course.

3. Faster Content Reviews

Anyone in pharma marketing knows how long content approval can take. GenAI is now helping to:

• Draft variants that follow brand rules
  
• Pre-fill standard compliance forms
  
• Speed up routine review steps
  

People still make the final call – but the process is a lot less painful.

4. Training that prepares, not just informs

Some companies are trialling GenAI avatars to simulate real conversations. Reps can:

• Practise tricky questions
  
• Try different messages
  
• Build confidence before speaking to HCPs
  

The result? More useful training, in less time.

Why these projects actually succeed

What do the successful examples have in common?

• The tools slot into current workflows
  
• The AI acts naturally and stays focused
  
• The goals are clear – and measurable
  
• People are part of the loop, shaping how the system works
  

These aren’t side projects. They’re solving real problems.

When GenAI tries to do too much

Not everything lands. We’ve seen projects stall when:

• No one owns the outcome
  
• Compliance is looped in too late
  
• There’s no plan for what comes after the pilot
  

And budget matters. Running large models isn’t free. If the value isn’t obvious, it won’t last.

The next step: smarter agents, not just smart prompts

As teams get more confident, the tools are shifting. We’re seeing AI agents that:

• Work across systems
  
• Use structured and unstructured data
  
• Learn from previous outputs
  

In market research, this means:

• Transcribing interviews
  
• Highlighting key points
  
• Matching themes with quant surveys
  

No extra handoffs. Just one tool that handles it all.

What makes or breaks these projects

The signs of success? We see the same ones again and again:

• Interfaces that feel natural – if you need a training manual, it’s too complex
  
• Checks and balancesare built in – people remain in charge
  
• Use of existing platforms – less time switching between tools
  
• Grounded responses – tied to verified internal sources
  

And one more thing: don’t start big. Start smart. Test, learn, then grow.

At Screver, we don’t chase trends. We solve problems. Our goal is to help pharma teams listen to their customers – and act faster.

That’s why we:

• Create feedback flows that are quick to approve and easy to fill out
  
• Use GenAI to analyse comments in real time, in any language
  
• Support teams in turning results into action, not just reports
  

We focus on what matters: making feedback work.

🎯 Curious where GenAI fits into your customer or HCP feedback work? 

Let’s talk. We’ll show you what’s possible without the fluff.